Ausgabe 9/2023
Inhalt (40 Artikel)
Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosis
Qiaolei Zhang, Lixia Zhu, De Zhou, Li Li, Wanzhuo Xie, Yamin Tan, Xiujin Ye
Are accessory spleen screening and resection in refractory immune cytopenia an effective strategy or a waste of resources?
Sergio Rodríguez-Rodríguez, José Miguel Álvarez-Blanco, Susana Sánchez-Díaz, Juan Rangel-Patiño, Ana Sierra-Salazar, Elia Apodaca-Chávez, Roberta Demichelis-Gómez
The mTORC1 pathway participate in hyper-function of B cells in immune thrombocytopenia
Yujiao Xiang, Lu Liu, Yu Hou, Shenghong Du, Shuqian Xu, Hai Zhou, Linlin Shao, Guosheng Li, Tianshu Yu, Qiang Liu, Meijuan Xue, Junhui Yang, Jun Peng, Ming Hou, Yan Shi
Age-related differences in risks and outcomes of 30-day readmission in adults with sickle cell disease
Ming Chen, Kenneth I. Ataga, Jane S. Hankins, Min Zhang, Justin D. Gatwood, Jim Y. Wan, James E. Bailey
Molecular insights into hereditary elliptocytosis and pyropoikilocytosis: NGS uncovers multiple potential candidate genes
Durjoy K. Shome, Priya Das, Ghadir A. Akbar, Safa Taha, Ameera Radhi, Khulood Al-Saad, Rehab Helmy
Insulin-like growth factor 1 receptor inhibits the proliferation of acute myeloid leukaemia cells via NK cell activation
ShuQing Wang, Xuan Wang, KaiNi Shen, Chong Wei, Jian Li
Platelet is an unfavorable prognostic biomarker and associated with leukemia stem cells and immunomodulatory factors in acute myeloid leukemia
Qing Zhang, Haotian Yan, Xiyang Ren, Linlin Liu, Juan Wang, Lulu Zhang, Yi Dong, Hui Qin, Qianshan Tao, Zhimin Zhai
Secular trend in disease burden of leukemia and its subtypes in China from 1990 to 2019 and its projection in 25 years
Dongdong Niu, Yumei Zhao, Jia Wang, Enlin Ye, Jiasheng Huang, Jie Liu, Xueying Huang, Suru Yue, Xuefei Hou, Jiayuan Wu
Trimethoprim-sulfamethoxazole prevents interstitial pneumonitis in B-cell lymphoma patients receiving chemotherapy: a propensity score matching analysis
Chunxiao Liu, Xuewu Zhang, Yanan Zhu, Juying Wei, Xingnong Ye, Chunmei Yang, Hongyan Tong, Wenyuan Mai, Min Yang, Jiejing Qian, Liping Mao, Haitao Meng, Jie Jin, Wenjuan Yu
Rapid molecular response to dasatinib in Ph-like acute lymphoblastic leukemia patients with ABL1 rearrangements: case series and literature review
Kai-Wen Tan, Yi-Yan Zhu, Qiao-Cheng Qiu, Man Wang, Hong-Jie Shen, Si-Man Huang, Han-Yu Cao, Chao-Ling Wan, Yan-Yan Li, Hai-Ping Dai, Sheng-Li Xue
Positron emission tomography to detect bone marrow involvement for patients with follicular lymphoma: a systematic review and meta-analysis
Yaxin Zheng, Jun Liu, Junqi Si, Qiang Xue, Dan Chen, Rexidan Nuermaimaiti, Chen Tian
MYC-targeted genes predict distant recurrence in patients with ocular adnexal extranodal marginal zone lymphoma
Tianyu Zhu, Jiahao Shi, Xiaowen Zhou, Cen Qiu, Ruobing Jia, Shiyun Huang, Renbing Jia, Yefei Wang, Xin Song, Yixiong Zhou
Prognostic value of soluble programmed cell death ligand-1 (sPD-L1) in lymphoma: a systematic review and meta-analysis
Yangyang Ding, Cheng Sun, Linhui Hu, Shudao Xiong, Zhimin Zhai
Clinical significance of plasma PD-L1+ exosomes in the management of diffuse large B cell lymphoma
Peng Xu, Juan Liu, Huijuan Chen, Limei Shang, Fei Wang, Yuandong Zhu, Yanting Guo, Feng Li, Feng Yan, Xiaobao Xie, Liang Li, Weiying Gu, Yan Lin
Clinical features and prognosis of pediatric acute lymphocytic leukemia with JAK-STAT pathway genetic abnormalities: a case series
Mengze Hu, Rong Liu, Juanjuan Li, Lei Zhang, Jing Cao, Mei Yue, Dixiao Zhong, Ruihong Tang
Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study
Jia-Ying Li, Xiao-Rong Hou, Si-Ye Chen, Xin Liu, Qiu-Zi Zhong, Li-Ting Qian, Xue-Ying Qiao, Hua Wang, Yuan Zhu, Jian-Zhong Cao, Jun-Xin Wu, Tao Wu, Su-Yu Zhu, Mei Shi, Hui-Lai Zhang, Xi-Mei Zhang, Hang Su, Yu-Qin Song, Jun Zhu, Yu-Jing Zhang, Hui-Qiang Huang, Ying Wang, Xia He, Li-Ling Zhang, Bao-Lin Qu, Yong Yang, Chen Hu, Min Deng, Shu-Lian Wang, Shu-Nan Qi, Ye-Xiong Li
Dynamic changes in circulating EBV-DNA load during treatment have prognostic values in EBV+ DLBCL-NOS: a Chinese cohort study
Tong-Yao Xing, Zi-Wen Duan, Wei-Ting Wang, Kai-Xin Du, Hao-Rui Shen, Hua Yin, Jia-Zhu Wu, Yue Li, Li Wang, Jian-Yong Li, Jin-Hua Liang, Wei Xu
ADAR1 polymorphisms contribute to increased susceptibility in pediatric acute lymphoblastic leukemia
Mansi Cai, Xiaoping Liu, Ailing Luo, Xu Yang, Yaping Yan, Shanshan Liu, Xueliang Wang, Ziyan Luo, Xuedong Wu, Ke Huang, Lihua Yang, Hua Jiang, Ling Xu, Xiaodan Liu
Efficacy and Safety of Ixazomib Plus Lenalidomide and Dexamethasone Following Injectable PI-Based Therapy in Relapsed/Refractory Multiple Myeloma
Yu Abe, Makoto Sasaki, Naoki Takezako, Shigeki Ito, Kazuhito Suzuki, Hiroshi Handa, Takaaki Chou, Takahiro Yoshida, Ikuo Mori, Tomohiro Shinozaki, Kenshi Suzuki
Correction to: Efficacy and safety of ixazomib plus lenalidomide and dexamethasone following injectable pi‑based therapy in relapsed/refractory multiple myeloma
Yu Abe, Makoto Sasaki, Naoki Takezako, Shigeki Ito, Kazuhito Suzuki, Hiroshi Handa, Takaaki Chou, Takahiro Yoshida, Ikuo Mori, Tomohiro Shinozaki, Kenshi Suzuki
Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JSTCT, Transplant Complications Working Group
Masuho Saburi, Kumi Oshima, Kuniko Takano, Yoshitaka Inoue, Kaito Harada, Naoyuki Uchida, Takahiro Fukuda, Noriko Doki, Kazuhiro Ikegame, Yayoi Matsuo, Yuta Katayama, Yukiyasu Ozawa, Ken-ichi Matsuoka, Toshiro Kawakita, Yasuo Mori, Takahide Ara, Hirohisa Nakamae, Takafumi Kimura, Yoshinobu Kanda, Yoshiko Atsuta, Masao Ogata
Allogeneic haematopoietic stem cell transplantation for myelofibrosis: prognostic indicators and the role of JAK2V617F measurable-residual disease monitoring by droplet-digital polymerase chain reaction
Vivian W.K. Li, Rita Yim, Paul Lee, Lynn Chin, Lester Au, Garret M.K. Leung, Joycelyn Sim, Albert K.W. Lie, Eric Tse, Yok-Lam Kwong, Harinder Gill
The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation is equally effective in relapse prevention but safer compared to spontaneous graft-versus-host disease
Michael Stadler, Lothar Hambach, Elke Dammann, Helmut Diedrich, Haytham Kamal, Iyas Hamwi, Christian Schultze-Florey, Michael Varvenne, Steve Ehrlich, Stefanie Buchholz, Christian Koenecke, Gernot Beutel, Eva M. Weissinger, Jürgen Krauter, Matthias Eder, Bernd Hertenstein, Arnold Ganser
Pretransplant spleen volume and outcome after hematopoietic stem cell transplantation (HSCT) in patients with acute myeloid leukemia (AML)
Alexander Pohlmann, Eva Bentgens, Christoph Schülke, David Kuron, Christian Reicherts, Julia Marx, Linus Angenendt, Jan-Henrik Mikesch, Georg Lenz, Matthias Stelljes, Christoph Schliemann
Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era — real-world data from Hungary
Kata Husi, Roxána Szabó, László Imre Pinczés, Dóra Földeák, Réka Dudley, Árpád Szomor, Beáta Koller, László Gopcsa, Árpád Illés, Zsófia Miltényi
Meta-analysis of the results of haploidentical transplantation in the treatment of aplastic anemia
Jin Zhao, Li Ma, Meijing Zheng, Liping Su, Xiaojing Guo
Time-dependent analysis of the impact on early cytomegalovirus reactivation of HLA mismatch and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation from related donors in acquired aplastic anemia
Fan Lin, Xinyu Dong, Yuanyuan Zhang, Yifei Cheng, Tingting Han, Xiaodong Mo, Haixia Fu, Wei Han, Fengrong Wang, Feifei Tang, Chenhua Yan, Yuqian Sun, Zhengli Xu, Yu Wang, Xiaohui Zhang, Xiaojun Huang, Lanping Xu
Antithrombotic secondary prophylaxis with low dose of apixaban or rivaroxaban in the onco-hematologic patients: comparison with non-neoplastic patients
A. Chistolini, A. Serrao, G.M. Assanto, A. Genoese, E. Baldacci, S. Ligia, M. Breccia, C. Santoro
Tigecycline as salvage treatment of febrile neutropenia in patients with haematological malignancies—a retrospective single-centre analysis of 200 cases
Daniel Geßner, Mirjeta Berisha, Torben Esser, Enrico Schalk
Comment on: JAK2 V617F-mutated polycythemia vera developing in a patient with a 20-year-long chronic myeloid leukemia at the time of first molecular response
Gerasimos Tsilimidos, Sabine Blum
Mast cell leukemia associated with essential thrombocythemia: a type of MCL-AHN (MCL-AMN)
Magda Zanelli, Francesca Sanguedolce, Maurizio Zizzo, Andrea Palicelli, Salvatore Magnasco, Lara Aprile, Valentina Fragliasso, Giuseppe Broggi, Rosario Caltabiano, Stefano Ascani
Paroxysmal nocturnal hemoglobinuria with ulcerative colitis
Kenta Hayashino, Yuki Fujiwara, Yuki Isokane, Haruna Tobita, Tomoko Inomata, Toshihiro Inokuchi, Takeru Asano, Shiro Kubonishi, Masahiro Takatani, Yasushi Hiramatsu
The efficacy of first salvage therapy determines the outcomes of adult patients with type 1 primary refractory acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Zhiyou Yu, Yao Yao, Yanming Zhang, Jia Chen, Yang Xu, Shengli Xue, Huiying Qiu, Xiaowen Tang, Yue Han, Suning Chen, Aining Sun, Depei Wu, Ying Wang
Characteristics and outcomes associated with venous thrombotic complications among patients with paroxysmal nocturnal hemoglobinuria
Udhayvir S. Grewal, Sahith R. Thotamgari, Shiva J. Gaddam, Rachaita Lakra, Usha Perepu
Administration of tocilizumab in septic patients with pancytopenia and hyper-inflammatory syndrome
Katarina Tomulic Brusich, Kazimir Juricic, Mirna Bobinac, Marko Milosevic, Alen Protic, Ana Boban
COVID-19 infection outcomes in patients receiving CD20 targeting T-cell engaging bispecific antibodies for B-cell non-Hodgkin lymphoma
Victoria R. Nachar, Anthony J. Perissinotti, Bernard L. Marini, Yasmin H. Karimi, Tycel J. Phillips
Cyclin D2-positive mantle cell lymphoma with t(2;12)(p12;p13) arising in immune deficiency/dysregulation
Takumi Kondo, Mitsuko Iguchi, Shohei Yoshida, Tadashi Yoshino, Kensuke Kojima
Erythema nodosum as a manifestation of cytokine release syndrome after CAR T-cell therapy
Delfim Duarte, José Mário Mariz
Correction to: RE‑MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola‑BR), CAR‑T therapies, and lenalidomide/rituximab (R2) based on real‑world data in patients with relapsed/refractory diffuse large B‑cell lymphoma
Grzegorz S. Nowakowski, Dok Hyun Yoon, Patrizia Mondello, Erel Joffe, Anthea Peters, Isabelle Fleury, Richard Greil, Matthew Ku, Reinhard Marks, Kibum Kim, Pier Luigi Zinzani, Judith Trotman, Lorenzo Sabatelli, Eva E. Waltl, Mark Winderlich, Andrea Sporchia, Nuwan C. Kurukulasuriya, Raul Cordoba, Georg Hess, Gilles Salles